MedTrace Logo

Inflammatory Markers and Resistant Depression

NCT02847533 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2016-07-28

No results posted yet for this study

Summary

This study focuses on blood inflammatory markers (pro-inflammatory cytokines, anti-inflammatory cytokines, monocytes costimulation molecules) in patients with resistant unipolar depression in comparison with non-resistant unipolar depressed patients.

Conditions

Interventions

PROCEDURE

blood sample

blood sample for concentration levels of inflammatory markers

BEHAVIORAL

psychometric scales

Mini international interview MADRS, C-SSRS, QIDS-SR, BIS-10, BDHI, BART, ERD

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Principal Investigators

  • Emmanuel Haffen, MD PhD · CHU Besançon

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-06-30
Completion
2018-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02847533 on ClinicalTrials.gov